Disparities in surgery among patients with intractable epilepsy in a universal health system

Neurology

Volumn 86, Issue 1, 2016, Pages 72-78

  Burneo, Jorge G ^a   Shariff, Salimah Z ^b   Liu, Kuan ^b   Leonard, Sean ^b   Saposnik, Gustavo ^b,c,d   Garg, Amit X ^b,e  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

^c ST MICHAEL'S HOSPITAL   (Canada)

^d UNIVERSITY OF ZURICH   (Switzerland)

^e WESTERN UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANADA; CLINICAL PRACTICE; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEALTH CARE ACCESS; HEALTH CARE DISPARITY; HUMAN; INCOME; INTRACTABLE EPILEPSY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; DRUG RESISTANT EPILEPSY; INSURANCE; NEUROSURGERY; ONTARIO; TREATMENT OUTCOME;

ADULT; AGED; COHORT STUDIES; DRUG RESISTANT EPILEPSY; FEMALE; HEALTHCARE DISPARITIES; HUMANS; MALE; MIDDLE AGED; NEUROSURGICAL PROCEDURES; ONTARIO; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; UNIVERSAL COVERAGE;

EID: 84952342893     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0000000000002249     Document Type: Article

References (29)

1. Tellez-Zenteno JF, Pondal-Sordo M, Matijevic S, Wiebe S. National and regional prevalence of selfreported epilepsy in Canada. Epilepsia 2004; 45: 1623-1629
2. Kwan P, Brodie MJ. Early identification of refractory epilepsy. N Engl J Med 2000; 342: 314-319
3. Brodie MJ, Barry SJ, Bamagous GA, Norrie JD, Kwan P. Patterns of treatment response in newly diagnosed epilepsy. Neurology 2012; 78: 1548-1554
4. Kwan P, Arzimanoglou A, Berg AT, et al. Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia 2010; 51: 1069-1077
5. Burneo JG, McLachlan RS. When should surgery be considered for the treatment of epilepsy? CMAJ 2005; 172: 1175-1177
6. Wiebe S, Blume WT, Girvin JP, Eliasziw M; Effectiveness, Efficiency of Surgery for Temporal Lobe Epilepsy Study Group. A randomized, controlled trial of surgery for temporal-lobe epilepsy. N Engl J Med 2001; 345: 311-318
7. Engel J Jr, McDermott MP, Wiebe S, et al. Early surgical therapy for drug-resistant temporal lobe epilepsy: a randomized trial. JAMA 2012; 307: 922-930
8. Engel J Jr, Wiebe S, French J, et al. Practice parameter: temporal lobe and localized neocortical resections for epilepsy: report of the Quality Standards Subcommittee of the American Academy of Neurology, in association with the American Epilepsy Society and the American Association of Neurological Surgeons. Neurology 2003; 60: 538-547
9. Jette N, Quan H, Tellez-Zenteno JF, et al. Development of an online tool to determine appropriateness for an epilepsy surgery evaluation. Neurology 2012; 79: 1084-1093
10. Burneo JG, Jette N, Theodore W, et al. Disparities in epilepsy: report of a systematic review by the North American Commission of the International League against Epilepsy. Epilepsia 2009; 50: 2285-2295
11. Levy AR, OBrien BJ, Sellors C, Grootendorst P, Willison D. Coding accuracy of administrative drug claims in the Ontario Drug Benefit database. Can J Clin Pharmacol 2003; 10: 67-71
12. The Ontario Drug Benefit Program. Available at: http://www.health.gov.on.ca/en/public/programs/drugs/programs/odb/odb.aspx. Accessed January 26, 2015
13. von Elm E, Altman DG, Egger M, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Epidemiology 2007; 18: 800-804
14. Austin PC, Mamdani MM, Tu K, Jaakkimainen L. Prescriptions for estrogen replacement therapy in Ontario before and after publication of the Womens Health Initiative Study. JAMA 2003; 289: 3241-3242
15. Alter DA, Naylor CD, Austin P, Tu JV. Effects of socioeconomic status on access to invasive cardiac procedures and on mortality after acute myocardial infarction. N Engl J Med 1999; 341: 1359-1367
16. Mamdani M, Juurlink DN, Lee DS, et al. Cyclo-oxygenase-2 inhibitors versus non-selective non-steroidal antiinflammatory drugs and congestive heart failure outcomes in elderly patients: a population-based cohort study. Lancet 2004; 363: 1751-1756
17. Juurlink DN, Mamdani MM, Lee DS, et al. Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study. N Engl J Med 2004; 351: 543-551
18. Gandhi S, Fleet JL, Bailey DG, et al. Calcium-channel blocker-clarithromycin drug interactions and acute kidney injury. JAMA 2013; 310: 2544-2553
19. Hwang YJ, Dixon SN, Reiss JP, et al. Atypical antipsychotic drugs and the risk for acute kidney injury and other adverse outcomes in older adults: a population-based cohort study. Ann Internal Med 2014; 161: 242-248
20. Garg AX, Nevis IF, McArthur E, et al. Gestational hypertension and preeclampsia in living kidney donors. N Engl J Med 2015; 372: 124-133
21. Jette N, Reid AY, Quan H, Hill MD, Wiebe S. How accurate is ICD coding for epilepsy? Epilepsia 2010; 51: 62-69
22. Reid AY, St Germaine-Smith C, Liu M, et al. Development and validation of a case definition for epilepsy for use with administrative health data. Epilepsy Res 2012; 102: 173-179
23. The Ontario Marginalization Index. Toronto: Center for Research on Inner City Health; 2012. Available at: http://crunch.mcmaster.ca/documents/ON-Marg-user-guide- 1.0-FINAL-MAY2012.pdf. Accessed January 26, 2015
24. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40: 373-383
25. Ibrahim GM, Rutka JT, Snead OC III. Epilepsy surgery in childhood: no longer the treatment of last resort. CMAJ 2014; 186: 973-974
26. Englot DJ, Ouyang D, Garcia PA, Barbaro NM, Chang EF. Epilepsy surgery trends in the United States, 1990-2008. Neurology 2012; 78: 1200-1206
27. Grimes DA. Epidemiologic research using administrative databases: garbage in, garbage out. Obstet Gynecol 2010; 116: 1018-1019
28. Suissa S, Garbe E. Primer: administrative health databases in observational studies of drug effects: advantages and disadvantages. Nat Clin Pract Rheumatol 2007; 3: 725-732
29. Wiebe S, Bellhouse DR, Fallahay C, Eliasziw M. Burden of epilepsy: the Ontario Health Survey. Can J Neurol Sci 1999; 26: 263-270